DCM
NBIX icon

Driehaus Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-108,547
Closed -$12M 472
2025
Q1
$12M Buy
108,547
+5,626
+5% +$622K 0.12% 218
2024
Q4
$14M Buy
102,921
+32,114
+45% +$4.38M 0.12% 208
2024
Q3
$8.16M Sell
70,807
-488
-0.7% -$56.2K 0.07% 246
2024
Q2
$9.82M Sell
71,295
-294
-0.4% -$40.5K 0.1% 219
2024
Q1
$9.87M Sell
71,589
-45,325
-39% -$6.25M 0.1% 235
2023
Q4
$15.4M Sell
116,914
-76,568
-40% -$10.1M 0.19% 186
2023
Q3
$21.8M Buy
193,482
+66,129
+52% +$7.44M 0.28% 115
2023
Q2
$12M Sell
127,353
-64,924
-34% -$6.12M 0.15% 196
2023
Q1
$19.5M Sell
192,277
-48,981
-20% -$4.96M 0.27% 119
2022
Q4
$28.8M Buy
241,258
+18,601
+8% +$2.22M 0.43% 70
2022
Q3
$23.6M Buy
222,657
+124,773
+127% +$13.3M 0.36% 89
2022
Q2
$9.54M Buy
+97,884
New +$9.54M 0.15% 203
2020
Q3
Sell
-2,585
Closed -$315K 429
2020
Q2
$315K Sell
2,585
-4,389
-63% -$535K 0.01% 338
2020
Q1
$604K Sell
6,974
-12,926
-65% -$1.12M 0.02% 289
2019
Q4
$2.14M Sell
19,900
-11,577
-37% -$1.24M 0.06% 273
2019
Q3
$2.84M Buy
+31,477
New +$2.84M 0.09% 217
2018
Q4
Sell
-17,893
Closed -$2.2M 479
2018
Q3
$2.2M Buy
17,893
+3,269
+22% +$402K 0.07% 272
2018
Q2
$1.44M Sell
14,624
-1,839
-11% -$181K 0.05% 305
2018
Q1
$1.37M Buy
16,463
+3,237
+24% +$268K 0.05% 306
2017
Q4
$1.03M Sell
13,226
-1,074
-8% -$83.3K 0.04% 339
2017
Q3
$876K Buy
+14,300
New +$876K 0.03% 335
2013
Q4
Sell
-78,764
Closed -$892K 494
2013
Q3
$892K Sell
78,764
-422,555
-84% -$4.79M 0.03% 355
2013
Q2
$6.71M Buy
+501,319
New +$6.71M 0.29% 104